Nanoescapology progress toward understanding the endosomal escape of polymeric nanoparticles

Purpose: Endosomal escape is widely considered the rate-limiting bottleneck for cytoplasmic delivery of nucleic acids, proteins, and other therapeutics using polymeric and lipid nanoparticles. The field lacks robust methods to quantify escape efficiency and understand its mechanisms, limiting rational design of improved delivery systems.

Hypothesis: This is a review article and does not test a single formal hypothesis. Its central premise is that a better understanding of nanoparticle internalization, intracellular trafficking, and endosomal escape mechanisms — combined with improved detection methods and rationally engineered pH-responsive or membrane-active materials — will enable more effective cytoplasmic delivery.

Aims: Review the mechanisms governing cellular internalization and intracellular trafficking of nanoparticles. - Discuss methods to detect and quantify endosomal escape, including their strengths and limitations. - Summarize recent advances in controlling endosomal escape from polymer- and lipid-based nanoparticles. - Highlight the need for quantitative assays and mechanistic understanding to guide the design of next-generation delivery systems.

Delivery system: Carrier types: Polymeric and lipid nanoparticles, polyplexes, lipoplexes, micelles, polymersomes, core–shell gel particles, pH-responsive nanoparticles, and polymer blend particles. - Polymers highlighted: PEI, PAMAM dendrimers, PDEAEMA, poly(β-amino ester) “poly-1,” PEG-b-PDEAEMA, PDMAEMA-b-PDPAEMA, PMPC-b-PDPAEMA, PAsp(DET), poly(L-histidine), poly(arginine), PPAA/PBA/BMA/DMAEMA micelles, PLGA blends. - Lipids: DOTAP, DOPE, DOPC, DODAC, PEG-lipids. - Peptides: TAT, Arg8, peptide 5.3, influenza HA2, GALA, KALA, shGALA, aurein 1.2, H4R4. - Payloads: siRNA, mRNA, plasmid DNA, proteins (GFP, caspase-3, OVA), antigens, and fluorescent markers such as calcein and dextran. - Triggers: Primarily pH-responsive disassembly, swelling, membrane disruption, or fusion; some mention of enzyme/reducing conditions.

Approach: Review of in vitro and in vivo literature. In vitro models include HeLa, DC2.4 dendritic cells, HepG2, HuH-7, HEK cells, primary human dermal fibroblasts, and primary T cells. In vivo examples include mouse vaccination/tumor models. No new primary experiments, group sizes, or doses are reported.

Key methods: Fluorescence microscopy and confocal imaging for punctate vs. diffuse cargo distribution. - Colocalization with organelle markers: LysoTracker, acridine orange, LAMP-1, EEA1, Rab4/5/7/11. - Flow cytometry, acid washing, trypan blue quenching, SHIP internalization sensor, and HD flow cytometry. - Liposome leakage assays and red blood cell hemolysis assays. - Calcein and fluorescent dextran leakage assays. - Transfection and RNAi reporter assays (luciferase, β-galactosidase, GFP). - DLS, SAXS, patch-clamp, electron microscopy, and molecular simulations for membrane interaction studies.

Key results: pH-responsive PDEAEMA core–shell particles: Swelled 2.8-fold in diameter from pH 7.4 to 5.0; approximately 90% of cells showed diffuse cytosolic calcein vs. <5% for controls; OVA antigen presentation gave 9–10-fold higher IFN-γ production. - Poly-1 nanoparticles: Rapidly degraded at low pH within 5 min; about 30% of cells were transfected with mRNA encoding GFP. - pHlexi nanoparticles: Induced endosomal escape in approximately 40% of cells; colocalization with lysosomes suggested membrane disruption or pore formation rather than complete vesicle rupture. - Zhan et al. blend particles: Diffuse cytosolic fluorescence for calcein and dextran up to 40 kDa, but not for 150 kDa or 2000 kDa dextran, indicating size-limited pores. - shGALA-modified PEG-MEND: Achieved 82% target gene knockdown; efficiency was reduced by NH₄Cl, indicating pH-dependent action. - PEGylation: Reduced endosomal escape; lowering PEG molecular weight from 3400 to 220 Da improved transfection. - TAT dimer: Enhanced endosomal escape at concentrations more than an order of magnitude lower than monomeric TAT. - Amphotericin B co-loading: Improved diffuse siRNA distribution and enhanced target knockdown.

Interpretation: Endosomal escape remains the major bottleneck for cytoplasmic delivery. The field must move beyond simply reporting the percentage of cells showing escape and develop assays that quantify escape efficiency and reveal mechanisms. Key open questions include how uptake pathway, nanoparticle size/shape/charge, targeting, and protein corona affect trafficking and escape. Next-generation gene therapy, vaccination, and cytosolic drug delivery depend on solving this problem.

Limitations: This is a review, not a primary study; no new experimental data or meta-analysis. - Mechanisms of endosomal escape remain contentious, especially the proton sponge hypothesis. - Detection methods have significant limitations: colocalization can underestimate escape, fixation/permeabilization can artifactually lose particles, dyes have background issues, and light can induce redistribution. - Many assays are low-throughput, indirect, or unable to quantify escape efficiency. - Promising in vitro results often do not translate to efficient in vivo delivery. - No large-animal validation or clinical trial data are presented.